ABBV is trading at -4.02% now at $220.09 as the stock experiences an unexplained drop ahead of a routine J.P. Morgan Healthcare Conference presentation.
- The current move diverges significantly from recent stability around $229$.
- The drop is occurring despite modest market gains elsewhere, such as CVX trading +7% pre-market on Venezuela news.
- The decline is likely attributable to broader sector rotation or profit-taking.